Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Autoimmune Diseases × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 11 Spondylitis, Ankylosing 4 Psoriasis 2 Inflammatory Bowel Diseases 2 Thyroid Carcinoma, Anaplastic 1 Spondylarthritis 1 Sarcoidosis 1 Osteoarthritis 1 Nephrotic Syndrome 1 Nephrosis, Lipoid 1 Mucopolysaccharidosis VI 1 Mucopolysaccharidosis II 1 Mucopolysaccharidosis I 1 Mucopolysaccharidoses 1 Macular dystrophy, corneal type 1 1 Kidney Diseases 1 Joint Diseases 1 Inflammation 1 Infections 1 Glomerulosclerosis, Focal Segmental 1 Dupuytren Contracture 1 Crohn Disease 1 Colitis, Ulcerative 1 Autoimmune Diseases 1 Arthritis, Psoriatic 1 Arthritis 1

Interventions

telitacicept 2 Prednisone 2 Blood Specimen Collection 2 thymoglobulin 1 remdesivir 1 prednylidene 1 fludarabine 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 apremilast 1 Vitamin D 1 Valsartan 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Pyridostigmine Bromide 1 Practice Guidelines as Topic 1 Population Groups 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Music Therapy 1 Methods 1 Melphalan 1 Mastectomy, Segmental 1 Mammaplasty 1 Interviews as Topic 1 Infliximab 1 Immunotherapy 1 Immunoglobulins, Intravenous 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡